Status: Recruiting
STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)
To evaluate the safety and efficacy of Siegel™ TAVR System in the treatment of subjects with symptomatic severe native aortic stenosis.
Participants needed: 1,025
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: MiRusUpdated: Apr 9, 2026Locations: 1
Eligibility criteria
Age ≥ 18 years [+7]
Cardiac anatomy precluding safe placement of a transcatheter aortic valve. [+35]